Publications

by | February 28, 2013 | Uncategorized

Problems with medicine shortages – European Pharmaceutical Students Association (EPSA) Annual Reception 2013

On 21 February 2013, EPHA attended the European Pharmaceutical Students Association (EPSA) Annual Reception at the European Parliament, entitled “Health Inequalities – Access to Medicines”. The event was hosted by MEP Elena Oana ANTONESCU (Romania, EPP) and MEP Marisa Matias (Portugal, GUE/NGL).

The EPSA reception brought together experts from the pharmaceutical arena, health professionals, as well as patients associations. The following speakers took part in the panel: Kaisa Immonen-Charalambous – European Patients’ Forum (EPF); John Chave – Pharmaceutical Group of the European Union (PGEU); Monika Derecque-Pois – The European Association of Pharmaceutical Full-Line Wholesalers (GIRP); Marie-Claire Pickaert – European Federation of Pharmaceutical Industries and Associations (EFPIA); Roberto Frontini – European Association of Hospital Pharmacists (EAHP); and Mounir Rizovsky – European Industrial Pharmacists Group (EIPG).

Marisa Matias MEP opened the session emphasising the importance of health inequalities and its impact on patients and their families. “Social inequalities increase health inequalities . For Ms Matias awareness needs to be increased and it is vital to reflect on whether health inequalities can be prevented.

EPF demonstrated its concerns about chronic diseases. The accessibility of medicines can have negative consequences on patients in different areas. Moreover, there are economic consequences, as delays incur additional costs: costs for healthcare providers/emergency care and social costs, amongst others. Hence, health inequalities should be a priority at European and national levels. Furthermore, Ms Immonen-Charamboulos called for more involvement of patients stating that involvement is essential in all processes for access to safe and quality health.

“Medicine shortages are widespread and do not respect national borders. This is something that urgently requires attention if patient care and health services are not to suffer”, stressed Dr Roberto Frontini of EPHA member EAHP. He presented two EAHP surveys carried out last year to understand the dimension of the problem. The first survey concerns the prevalence of the shortages and the second one is related to what hospital pharmacists consider to be the impact to patient care from medicine shortages, as well as their perception of the principal causes and solutions. Both surveys were conducted amongst hospital pharmacists from 27 countries and they demonstrate that problems are bigger than many people realise given that shortages occur weekly and sometimes even daily.

Some of the most important results are summarised below:

  • 99% of respondents say they experienced problems with medicine shortages during the past year (survey 1);
  • 71% of respondents identified oncology medicines as an area commonly experiencing shortages (survey 1);
  • 52% of respondents cited supply chain vulnerability from only having a single, or a small number of suppliers of a product as a perceived principal cause of shortage problems (survey 2).

The full results of these surveys will be published by EAHP at its forthcoming Congress in Paris on 13-15th March, 2013.

For more information:

  • [99% of hospital pharmacists experience difficulties with medicine shortages in past year

->https://www.eahp.eu/press-room/99-hospital-pharmacists-experience-difficulties-medicines-shortages-past-year];

——
EPHA related articles:

Get the EPHA Newsletter

The best of our activities, right in your inbox!